Gossamer Bio, Inc. Income Statement

Income Statement Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Revenue & cost
Revenue -0.01M-1.94M-12.67M-19.44M-13.88M-13.51M90.70M
Gross Profit -0.01M-1.94M-12.67M-19.44M-13.88M-13.51M90.70M
Operating items
Research & Development 55.28M143.40M160.85M170.27M170.92M135.30M138.49M
Selling, General & Administrative 44.05M39.14M49.73M45.78M47.61M38.45M36.13M
Other Operating Expenses 49.66M3.60M23.38M0.07M0.07M10.00M
Operating Expenses 148.99M186.14M233.96M216.12M218.59M183.76M174.62M
Operating Income -148.99M-186.14M-233.96M-216.12M-218.59M-183.76M-59.92M
EBIT -148.99M-186.14M-233.96M-216.12M-218.59M-183.76M-59.92M
Non-operating items
Interest & Investment Income 1.72M5.56M3.44M0.76M1.58M2.00M1.78M
Other Non Operating Income 0.32M2.21M-0.17M0.80M1.51M15.46M14.02M
Non Operating Income 2.02M5.83M-9.40M-17.88M-10.79M15.46M14.02M
Net income details
EBT -147.28M-182.51M-243.19M-234.80M-229.38M-179.82M-55.63M
Tax Provisions 0.89M
Profit After Tax -146.97M-180.31M-243.36M-234.00M-229.38M-179.82M-56.53M
Income from Continuing Operations -147.28M-182.51M-243.19M-234.80M-229.38M-179.82M-56.53M
Consolidated Net Income -147.28M-182.51M-243.19M-234.80M-229.38M-179.82M-56.53M
Income towards Parent Company -147.28M-182.51M-243.19M-234.80M-229.38M-179.82M-56.53M
Net Income towards Common Stockholders -147.28M-182.51M-243.19M-234.80M-229.38M-179.82M-56.53M
Additional items
EPS (Basic) -0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M
EPS (Weighted Average and Diluted) -0.00M-0.00M-0.00M-0.00M-0.00M-0.00M
Shares Outstanding (Weighted Average) 60.40M66.04M75.93M76.46M94.48M225.41M226.60M
Shares Outstanding (Diluted Average) 84.57M152.62M226.23M
EBITDA -147.03M-179.99M-243.02M-234.56M-230.00M-179.59M-54.99M